DRNA News & Mentions

Popular stocks:

Mullen Automotive

TOP stocks:

Shares of other companies:

NOW

Blink Charging

JinkoSolar Holding Co.

Dicerna Pharmaceuticals (DRNA) Stock Forecast for 2023 – 2026. Sell or Buy?

Last update: June 8, 2023 (09:27)

Sector: Healthcare

The share price of Dicerna Pharmaceuticals, Inc. (DRNA) now

What analysts predict: $

52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Dicerna Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Dicerna Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Dicerna Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Dicerna Pharmaceuticals stock price in 2023, 2024, 2025, 2026, 2027. How much will one Dicerna Pharmaceuticals share be worth in 2023 - 2027?

When should I take profit in Dicerna Pharmaceuticals stock? When should I record a loss on Dicerna Pharmaceuticals stock? What are analysts' forecasts for Dicerna Pharmaceuticals stock? What is the future of Dicerna Pharmaceuticals stock? We forecast Dicerna Pharmaceuticals stock performance using neural networks based on historical data on Dicerna Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Dicerna Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Dicerna Pharmaceuticals shares. This happens once a day.

Historical and forecast chart of Dicerna Pharmaceuticals stock

The chart below shows the historical price of Dicerna Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Dicerna Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Dicerna Pharmaceuticals daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
Jun 10	39.22	38.76	39.70	2.43
Jun 11	39.61	39.28	40.52	3.16
Jun 12	39.86	39.28	40.36	2.76
Jun 13	39.01	38.76	39.48	1.87
Jun 14	39.34	39.02	39.91	2.29
Jun 15	39.02	38.46	40.00	4.03
Jun 16	38.56	37.96	39.26	3.41
Jun 17	38.15	37.66	38.64	2.59
Jun 18	38.99	38.64	39.45	2.10
Jun 19	37.89	37.61	38.75	3.03
Jun 20	37.92	36.99	38.68	4.56
Jun 21	39.07	38.27	39.92	4.31
Jun 22	38.76	38.46	39.33	2.26
Jun 23	39.09	38.55	39.58	2.66
Jun 24	39.79	39.50	40.53	2.61
Jun 25	39.64	38.84	40.51	4.31
Jun 26	40.22	39.64	40.70	2.66
Jun 27	40.26	39.95	40.76	2.03
Jun 28	39.33	38.38	39.84	3.80
Jun 29	38.26	37.82	39.22	3.69
Jun 30	37.86	37.00	38.33	3.60
Jul 01	37.27	36.43	37.85	3.90
Jul 02	37.06	36.38	37.30	2.54
Jul 03	36.74	36.27	36.98	1.94
Jul 04	37.12	36.82	37.78	2.61
Jul 05	37.67	37.16	38.28	3.02
Jul 06	37.23	36.37	38.10	4.75
Jul 07	37.72	36.76	38.60	5.02
Jul 08	38.00	37.74	38.45	1.87
Jul 09	37.78	37.50	38.30	2.13

Dicerna Pharmaceuticals Daily Price Targets

Dicerna Pharmaceuticals Stock Forecast 06-10-2023.

Forecast target price for 06-10-2023: $39.22.
Positive dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 2.371%.
Pessimistic target level: 38.76
Optimistic target level: 39.70

Dicerna Pharmaceuticals Stock Forecast 06-11-2023.

Forecast target price for 06-11-2023: $39.61.
Positive dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 3.065%.
Pessimistic target level: 39.28
Optimistic target level: 40.52

Dicerna Pharmaceuticals Stock Forecast 06-12-2023.

Forecast target price for 06-12-2023: $39.86.
Positive dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 2.686%.
Pessimistic target level: 39.28
Optimistic target level: 40.36

Dicerna Pharmaceuticals Stock Forecast 06-13-2023.

Forecast target price for 06-13-2023: $39.01.
Negative dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 1.834%.
Pessimistic target level: 38.76
Optimistic target level: 39.48

Dicerna Pharmaceuticals Stock Forecast 06-14-2023.

Forecast target price for 06-14-2023: $39.34.
Positive dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 2.240%.
Pessimistic target level: 39.02
Optimistic target level: 39.91

Dicerna Pharmaceuticals Stock Forecast 06-15-2023.

Forecast target price for 06-15-2023: $39.02.
Negative dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 3.870%.
Pessimistic target level: 38.46
Optimistic target level: 40.00

DRNA (DRNA) Monthly Stock Prediction for 2023

Month	Target	Pes.	Opt.	Vol., %
Jul.	35.96	32.68	39.81	17.92
Aug.	36.88	34.28	38.53	11.03
Sep.	34.22	31.43	38.33	18.00
Oct.	35.76	31.29	37.59	16.74
Nov.	36.73	34.55	41.25	16.24
Dec.	34.50	31.18	37.53	16.91

Full forecast for 2023

Dicerna Pharmaceuticals forecast for this year

Dicerna Pharmaceuticals Stock Prediction for Jul 2023

An downtrend is forecast for this month with an optimal target price of $35.9574. Pessimistic: $32.68. Optimistic: $39.81

Dicerna Pharmaceuticals Stock Prediction for Aug 2023

An uptrend is forecast for this month with an optimal target price of $36.8779. Pessimistic: $34.28. Optimistic: $38.53

Dicerna Pharmaceuticals Stock Prediction for Sep 2023

An downtrend is forecast for this month with an optimal target price of $34.2227. Pessimistic: $31.43. Optimistic: $38.33

Dicerna Pharmaceuticals Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $35.7559. Pessimistic: $31.29. Optimistic: $37.59

Dicerna Pharmaceuticals Stock Prediction for Nov 2023

An uptrend is forecast for this month with an optimal target price of $36.7284. Pessimistic: $34.55. Optimistic: $41.25

Dicerna Pharmaceuticals Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $34.4953. Pessimistic: $31.18. Optimistic: $37.53

Dicerna Pharmaceuticals (DRNA) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan	34.83	30.54	38.89	21.49
Feb	32.88	29.30	34.93	16.11
Mar	31.88	28.71	35.60	19.34
Apr	32.74	31.43	36.73	14.41
May	29.50	28.08	32.52	13.64
Jun	27.61	25.13	28.80	12.73
Jul	28.98	25.69	30.00	14.37
Aug	27.96	26.62	29.43	9.57
Sep	26.39	24.03	28.67	16.20
Oct	25.12	22.11	26.41	16.29
Nov	25.49	24.06	27.48	12.46
Dec	26.42	25.58	29.60	13.57

Full forecast for 2024

Dicerna Pharmaceuticals (DRNA) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	29.76	27.62	33.38	17.26
Feb	25.38	24.00	26.72	10.18
Mar	26.07	22.99	27.95	17.76
Apr	27.37	24.35	28.99	16.01
May	29.21	26.82	31.36	14.46
Jun	30.42	28.81	33.44	13.83
Jul	34.17	31.33	37.39	16.23
Aug	33.18	29.42	34.83	15.55
Sep	34.30	31.50	36.11	12.77
Oct	36.00	34.10	40.15	15.06
Nov	36.98	35.44	39.88	11.13
Dec	34.02	30.97	37.61	17.66

Full forecast for 2025

Dicerna Pharmaceuticals (DRNA) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	29.88	26.78	32.80	18.37
Feb	33.28	30.35	37.54	19.15
Mar	33.71	32.14	35.27	8.87
Apr	33.44	30.81	34.72	11.25
May	31.35	28.89	32.45	10.97
Jun	30.70	27.26	33.64	18.98
Jul	33.30	29.14	34.90	16.49
Aug	32.61	29.32	33.91	13.54
Sep	34.96	32.38	37.03	12.54
Oct	36.02	32.62	40.17	18.79
Nov	34.58	30.48	38.45	20.72
Dec	32.03	29.21	35.11	16.79

Full forecast for 2026

Dicerna Pharmaceuticals (DRNA) Monthly Stock Prediction for 2027

Month	Target	Pes.	Opt.	Vol., %
Jan	31.06	28.62	33.49	14.54
Feb	29.67	28.48	30.85	7.69
Mar	33.23	29.35	35.14	16.49
Apr	35.09	32.17	38.40	16.23
May	38.12	34.22	42.69	19.86
Jun	36.35	34.90	39.26	11.11
Jul	41.99	37.09	43.74	15.21
Aug	41.99	38.23	43.74	12.60
Sep	47.70	45.03	53.66	16.07
Oct	49.31	46.70	52.54	11.11
Nov	53.17	47.98	57.26	16.20
Dec	52.75	48.87	56.12	12.93

Full forecast for 2027

Dicerna Pharmaceuticals information and performance

Biopharmaceutical company Dicerna Pharmaceuticals, Inc. specializes in the discovery and development of pharmaceuticals based on the interference of ribonucleic acid (RNAi). The company develops pharmaceuticals using its GalXC RNAi platform to treat liver diseases, including rare diseases, viral infections, chronic liver diseases, and cardiometabolic diseases.

Dicerna Pharmaceuticals Address

N/A

Market Capitalization: N/A $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

Quidel Corp. (QDEL)

Esperion Therapeutics, Inc. (ESPR)

RenovoRx, Inc. (RNXT)

Hoth Therapeutics, Inc. (HOTH)

Medicenna Therapeutics Corp. (MDNA)

Centene Corp. (CNC)

Journey Medical Corp. (DERM)

Virios Therapeutics, Inc. (VIRI)

Ensysce Biosciences, Inc. (ENSC)

GlaxoSmithKline plc (GSK)

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

<img data-src="/images/stock/DRNA.svg" class="img_30 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img_30" src="/images/stock/DRNA.svg"> Dicerna Pharmaceuticals (DRNA) Stock Forecast for 2023 – 2026. Sell or Buy?